This article has been updated from a previous version to include comments from Nanosphere.

NEW YORK (GenomeWeb News) – Eppendorf said today that it has initiated an import ban against molecular diagnostics workstations and kits sold by Nanosphere because they allegedly infringe patents owned by Eppendorf that relate to microarray-based products.

The import ban covers any and all imports of Northbrook, Ill.-based Nanosphere's Verigene and Verigene SP systems into any country of the European Union, Eppendorf said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.

Oct
17
Sponsored by
Lexogen

This webinar will present a method for RNA-seq expression analysis of FFPE-derived RNA samples that are too degraded for successful application of standard RNA-seq techniques.

Oct
25
Sponsored by
Roche

This webinar will detail a comprehensive strategy that a lab has put in place to evaluate  NGS oncology assays for genomic tumor profiling of plasma and tissue samples.